培养人角膜内皮细胞注射后黄斑囊样水肿的频率、相关因素与视力结局
这项多中心回顾性队列研究纳入57眼接受培养人角膜内皮细胞注射治疗,术后26.3%发生黄斑囊样水肿(CME)。所有CME经局部非甾体抗炎药或球周注射曲安奈德后消退,6个月最佳矫正视力无显著差异。
要点
- cHCEC注射术后约四分之一眼发生CME,多见于术后早期。
- 术前使用前列腺素类似物、青光眼、局部降眼压药及较差术前视力与CME相关。
- CME经局部非甾体抗炎药或球周曲安奈德治疗后均消退,不影响6个月视力。
核心结论
- cHCEC注射治疗后约26.3%的眼可检出CME,术前前列腺素类似物使用与CME发生显著相关。
- 多数CME在术后早期检出,经治疗后消退,未对6个月最佳矫正视力产生不良影响。
研究设计与样本
- 多中心回顾性临床队列研究,纳入日本3家三级眼科机构的57例患者57眼。
- CME定义为谱域光学相干断层扫描检测到视网膜内囊样间隙,伴或不伴黄斑增厚。
- 采用单因素分析评估术后CME相关临床因素,并用Kaplan-Meier分析评估术前前列腺素类似物使用与CME检出时间的关系。
主要发现
- 57眼中15眼(26.3%)术后检出CME。
关键数值与推荐
- CME检出率为26.3%(15/57眼)。
临床怎么用
- 围手术期应谨慎管理前列腺素类似物的使用。
- 术后常规进行光学相干断层扫描有助于早期发现和管理CME。
局限性
- 57眼中50眼术前黄斑状态未确定,无法明确排除既存CME。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the frequency, timing, factors associated with, and visual impact of cystoid macular edema (CME) detected after cultured human corneal endothelial cell (cHCEC) injection therapy. DESIGN: Multicenter retrospective clinical cohort study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Fifty-seven eyes of 57 patients who underwent cHCEC injection therapy at 3 tertiary ophthalmic institutions in Japan. METHODS, INTERVENTION, OR TESTING: Clinical records were reviewed retrospectively. CME was defined as the presence of intraretinal cystoid spaces with or without macular thickening detected by spectral-domain optical coherence tomography. Clinical factors associated with postoperative CME were evaluated using univariate analyses. Kaplan-Meier analysis was performed to assess time to postoperative detection of CME according to preoperative prostaglandin analog use. MAIN OUTCOME MEASURES: Postoperative detection of CME, time to CME detection, and postoperative best-corrected visual acuity (BCVA) at 6 months. RESULTS: CME was detected postoperatively in 15 of 57 eyes (26.3%). Preoperative prostaglandin analog use was significantly associated with postoperative CME detection (9/15 [60.0%] vs 6/42 [14.3%], P = .001). Glaucoma (p = .006), use of topical glaucoma medications (p = .006), and worse preoperative BCVA (p = .003) were also associated with CME detection. Kaplan-Meier analysis demonstrated that CME was detected predominantly in the early postoperative period and was significantly more frequent in eyes treated with prostaglandin analogs than in those without prostaglandin analog use (log-rank p = .002). All CME cases resolved following treatment with topical nonsteroidal anti-inflammatory drugs or sub-Tenon triamcinolone acetonide injection. Six-month postoperative BCVA did not differ significantly between eyes with and without CME (logMAR, 0.44 vs 0.60; p = .52). Lens status was not significantly associated with postoperative CME (p = .325). Preoperative macular status was undetermined in 50 of 57 eyes; therefore, pre-existing CME could not be definitively excluded in these eyes. CONCLUSIONS: CME was detected postoperatively in approximately one-quarter of eyes after cHCEC injection therapy and was associated with preoperative prostaglandin analog use. Most cases were detected during the early postoperative period and resolved with treatment without adversely affecting 6-month visual outcomes. Careful perioperative management of prostaglandin analogs and routine postoperative optical coherence tomography may facilitate early detection and management of CME.
引用
- Ogino R, Shirane M, Yagi-Yaguchi Y, et al. Cystoid Macular Edema After Cultured Human Corneal Endothelial Cell Injection: Frequency, Associated Factors, and Visual Outcomes. Am J Ophthalmol. 2026. PMID: 42722115. doi:10.1016/j.ajo.2026.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。